Question 1

How does MK0869 compare to other nausea medications I might use?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) clinical trial (NCT00092196). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from MK0869?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) clinical trial (NCT00092196). Contact the study team or your healthcare provider for specific answers.

Question 3

How will this treatment fit into my overall chemotherapy plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) clinical trial (NCT00092196). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) clinical trial (NCT00092196). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience nausea despite taking this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) clinical trial (NCT00092196). Contact the study team or your healthcare provider for specific answers.

What this study is about